Abstract
Protein phosphorylation and post-phosphorylation events regulate many cellular signaling pathways. Peptidyl-prolyl isomerase (Pin1) is the only peptidyl-prolyl cis/trans isomerase that interacts with numerous oncogenic or tumor suppressive phosphorylated proteins, causes conformational changes in target proteins, and eventually regulates the activities of such proteins. These alterations in activity play a pivotal role in tumorigenesis. Since Pin1 is overexpressed and/or activated in various types of cancers, and the dysregulation of proline-directed phosphorylation contributes to tumorigenesis, Pin1 represents an attractive target for cancer therapy. This review will describe the role of Pin1 in cancer and the current status of Pin1 inhibitor development.
Similar content being viewed by others
References
Aluise CD, Camarillo JM, Shimozu Y, Galligan JJ, Rose KL, Tallman KA, Marnett LJ (2015) Site-specific, intramolecular cross-linking of Pin1 active site residues by the lipid electrophile 4-oxo-2-nonenal. Chem Res Toxicol 28:817–827. doi:10.1021/acs.chemrestox.5b00038
Atkinson GP, Nozell SE, Harrison DK, Stonecypher MS, Chen D, Benveniste EN (2009) The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma. Oncogene 28:3735–3745. doi:10.1038/onc.2009.232
Ayala G, Wang D, Wulf G, Frolov A, Le R, Wheeler T, Sowadski JM, Lu KP, Bao L (2003) Pin1 is a novel prognostic marker in prostate cancer. Cancer Res 63:6244–6251
Baik SH, Fane M, Park JH, Cheng YL, Yang-Wei Fann D, Yun UJ, Choi Y, Park JS, Chai BH, Park JS, Back SH, Jeong JI, Jang YJ, Bahn G, Lee JY, Li YI, Sobey CG, Uchida T, Park JH, Kim HT, Tang SC, Arumugam TV, Jo DG (2015) Pin1 promotes neuronal death in stroke by stabilizing Notch intracellular domain. Ann Neurol 77:504–516. doi:10.1002/ana.24347
Bao L, Sauter G, Sowadski J, Lu KP, Wang D (2004) Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Pathol 164:1727–1737
Bhaskaran N, van Drogen F, Ng HF, Kumar R, Ekholm-Reed S, Peter M, Sangfelt O, Reed SI (2013) Fbw7alpha and Fbw7gamma collaborate to shuttle cyclin E1 into the nucleolus for multiubiquitylation. Mol Cell Biol 33:85–97. doi:10.1128/MCB.00288-12
Blume-Jensen P, Hunter T (2001) Oncogenic kinase signalling. Nature 411:355–365
Brenkman AB, de Keizer PL, van den Broek NJ, van der Groep P, van Diest PJ, van der Horst A, Smits AM, Burgering BM (2008) The peptidyl-isomerase Pin1 regulates p27kip1 expression through inhibition of Forkhead box O tumor suppressors. Cancer Res 68:7597–7605. doi:10.1158/0008-5472.CAN-08-1059
Brondani V, Schefer Q, Hamy F, Klimkait T (2005) The peptidyl-prolyl isomerase Pin1 regulates phospho-Ser77 retinoic acid receptor alpha stability. Biochem Biophys Res Commun 328:6–13. doi:10.1016/j.bbrc.2004.12.130
Chen CH, Chang CC, Lee TH, Luo M, Huang P, Liao PH, Wei S, Li FA, Chen RH, Zhou XZ, Shih HM, Lu KP (2013) SENP1 deSUMOylates and regulates Pin1 protein activity and cellular function. Cancer Res 73:3951–3962. doi:10.1158/0008-5472.CAN-12-4360
Cho YS, Park SY, Kim DJ, Lee SH, Woo KM, Lee KA, Lee YJ, Cho YY, Shim JH (2012) TPA-induced cell transformation provokes a complex formation between Pin1 and 90 kDa ribosomal protein S6 kinase 2. Mol Cell Biochem 367:85–92. doi:10.1007/s11010-012-1322-y
Cho YA, Jue SS, Bae WJ, Heo SH, Shin SI, Kwon IK, Lee SC, Kim EC (2015) PIN1 inhibition suppresses osteoclast differentiation and inflammatory responses. J Dent Res 94:371–380. doi:10.1177/0022034514563335
Costantino S, Paneni F, Luscher TF, Cosentino F (2016) Pin1 inhibitor Juglone prevents diabetic vascular dysfunction. Int J Cardiol 203:702–707. doi:10.1016/j.ijcard.2015.10.221
Datta S, Banerjee A, Chandra PK, Chakravarty R (2007) Pin1-HBx interaction: a step toward understanding the significance of hepatitis B virus genotypes in hepatocarcinogenesis. Gastroenterology 133:727–728. doi:10.1053/j.gastro.2007.06.033 (author reply 728–9)
de The H, Chen Z (2010) Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nat Rev 10:775–783. doi:10.1038/nrc2943
de The H, Le Bras M, Lallemand-Breitenbach V (2012) The cell biology of disease: acute promyelocytic leukemia, arsenic, and PML bodies. J Cell Biol 198:11–21. doi:10.1083/jcb.201112044
Ding Q, Huo L, Yang JY, Xia W, Wei Y, Liao Y, Chang CJ, Yang Y, Lai CC, Lee DF, Yen CJ, Chen YJ, Hsu JM, Kuo HP, Lin CY, Tsai FJ, Li LY, Tsai CH, Hung MC (2008) Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer. Cancer Res 68:6109–6117. doi:10.1158/0008-5472.CAN-08-0579
Dougherty MK, Müller J, Ritt DA, Zhou XZ, Zhou M, Copeland TD, Conrads TP, Veenstra T, Lu KP, Morrison DK (2005) Regulation of Raf-1 by direct feedback phosphorylation. Mol Cell 17:215–224
Dourlen P, Ando K, Hamdane M, Begard S, Buee L, Galas MC (2007) The peptidyl prolyl cis/trans isomerase Pin1 downregulates the Inhibitor of Apoptosis Protein Survivin. Biochim Biophys Acta 1773:1428–1437. doi:10.1016/j.bbamcr.2007.05.012
Eckerdt F, Yuan J, Saxena K, Martin B, Kappel S, Lindenau C, Kramer A, Naumann S, Daum S, Fischer G, Dikic I, Kaufmann M, Strebhardt K (2005) Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells. J Biol Chem 280:36575–36583
Estey MP, Di Ciano-Oliveira C, Froese CD, Fung KY, Steels JD, Litchfield DW, Trimble WS (2013) Mitotic regulation of SEPT9 protein by cyclin-dependent kinase 1 (Cdk1) and Pin1 protein is important for the completion of cytokinesis. J Biol Chem 288:30075–30086
Fan G, Fan Y, Gupta N, Matsuura I, Liu F, Zhou XZ, Lu KP, Gelinas C (2009) Peptidyl-prolyl isomerase Pin1 markedly enhances the oncogenic activity of the rel proteins in the nuclear factor-kappaB family. Cancer Res 69:4589–4597. doi:10.1158/0008-5472.CAN-08-4117
Fischer G, Aumuller T (2003) Regulation of peptide bond cis/transisomerization by enzyme catalysis and its implication in physiological processes. Rev Physiol Biochem Pharmacol 148:105–150
Franciosa G, Diluvio G, Del Gaudio F, Giuli MV, Palermo R, Grazioli P, Campese AF, Talora C, Bellavia D, D’Amati G, Besharat ZM, Nicoletti C, Siebel CW, Choy L, Rustighi A, Del Sal G, Screpanti I, Checquolo S (2016) Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression. Oncogene. doi:10.1038/onc.2016.5
Gianni M, Boldetti A, Guarnaccia V, Rambaldi A, Parrella E, Raska I Jr, Rochette-Egly C, Del Sal G, Rustighi A, Terao M, Garattini E (2009) Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha. Cancer Res 69:1016–1026. doi:10.1158/0008-5472.CAN-08-2603
Girardini JE, Napoli M, Piazza S, Rustighi A, Marotta C, Radaelli E, Capaci V, Jordan L, Quinlan P, Thompson A, Mano M, Rosato A, Crook T, Scanziani E, Means AR, Lozano G, Schneider C, Del Sal G (2011) A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. Cancer Cell 20:79–91
Han HJ, Kwon N, Choi MA, Jung KO, Piao JY, Ngo HK, Kim SJ, Kim DH, Chung JK, Cha YN, Youn H, Choi BY, Min SH, Surh YJ (2016) Peptidyl prolyl isomerase PIN1 directly binds to and stabilizes hypoxia-inducible factor-1alpha. PLoS One 11:e0147038. doi:10.1371/journal.pone.0147038
Hennig L, Christner C, Kipping M, Schelbert B, Rucknagel KP, Grabley S, Kullertz G, Fischer G (1998) Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry 37:5953–5960. doi:10.1021/bi973162p
Hilton BA, Li Z, Musich PR, Wang H, Cartwright BM, Serrano M, Zhou XZ, Lu KP, Zou Y (2015) ATR plays a direct antiapoptotic role at mitochondria, which is regulated by prolyl isomerase Pin1. Mol Cell 60:35–46
Hwang YC, Yang CH, Lin CH, Ch’ang HJ, Chang VH, Yu WC (2013) Destabilization of KLF10, a tumor suppressor, relies on thr93 phosphorylation and isomerase association. Biochim Biophys Acta 1833:3035–3045. doi:10.1016/j.bbamcr.2013.08.010
Ito K, Bernardi R, Morotti A, Matsuoka S, Saglio G, Ikeda Y, Rosenblatt J, Avigan DE, Teruya-Feldstein J, Pandolfi PP (2008) PML targeting eradicates quiescent leukaemia-initiating cells. Nature 453:1072–1078. doi:10.1038/nature07016
Jalouli M, Dery MA, Lafleur VN, Lamalice L, Zhou XZ, Lu KP, Richard DE (2014) The prolyl isomerase Pin1 regulates hypoxia-inducible transcription factor (HIF) activity. Cell Signal 26:1649–1656. doi:10.1016/j.cellsig.2014.04.005
Jeong HG, Pokharel YR, Lim SC, Hwang YP, Han EH, Yoon JH, Ahn SG, Lee KY, Kang KW (2009) Novel role of Pin1 induction in type II collagen-mediated rheumatoid arthritis. J Immunol 183:6689–6697. doi:10.4049/jimmunol.0901431
Jeong K, Kim SJ, Oh Y, Kim H, Lee YS, Kwon BS, Park S, Park KC, Yoon KS, Kim SS, Ha J, Kang I, Choe W (2014) p53 negatively regulates Pin1 expression under ER stress. Biochem Biophys Res Commun 454:518–523
Kamimura T, Miyamoto T, Nagafuji K, Numata A, Henzan H, Takase K, Ito Y, Ohno Y, Fujisaki T, Eto T, Takamatsu Y, Teshima T, Gondo H, Akashi K, Taniguchi S, Harada M (2011) Role of autotransplantation in the treatment of acute promyelocytic leukemia patients in remission: fukuoka BMT Group observations and a literature review. Bone Marrow Transplant 46:820–826. doi:10.1038/bmt.2010.207
Kastner P, Lawrence HJ, Waltzinger C, Ghyselinck NB, Chambon P, Chan S (2001) Positive and negative regulation of granulopoiesis by endogenous RARalpha. Blood 97:1314–1320
Keune WJ, Jones DR, Bultsma Y, Sommer L, Zhou XZ, Lu KP, Divecha N (2012) Regulation of phosphatidylinositol-5-phosphate signaling by Pin1 determines sensitivity to oxidative stress. Sci Signal 5:ra86
Khanal P, Yun HJ, Lim SC, Ahn SG, Yoon HE, Kang KW, Hong R, Choi HS (2012) Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells. Oncogene 31:3845–3856. doi:10.1038/onc.2011.548
Khanal P, Kim G, Lim SC, Yun HJ, Lee KY, Choi HK, Choi HS (2013) Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer. FASEB J 27:4606–4618. doi:10.1096/fj.13-236851
Kondo A, Shahpasand K, Mannix R, Qiu J, Moncaster J, Chen CH, Yao Y, Lin YM, Driver JA, Sun Y, Wei S, Luo ML, Albayram O, Huang P, Rotenberg A, Ryo A, Goldstein LE, Pascual-Leone A, McKee AC, Meehan W, Zhou XZ, Lu KP (2015) Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy. Nature 523:431–436. doi:10.1038/nature14658
La Montagna R, Caligiuri I, Maranta P, Lucchetti C, Esposito L, Paggi MG, Toffoli G, Rizzolio F, Giordano A (2012) Androgen receptor serine 81 mediates Pin1 interaction and activity. Cell Cycle (Georget Tex) 11:3415–3420
Lee NY, Choi HK, Shim JH, Kang KW, Dong Z, Choi HS (2009a) The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation. Carcinogenesis 30:671–681. doi:10.1093/carcin/bgp027
Lee TH, Tun-Kyi A, Shi R, Lim J, Soohoo CY, Finn G, Balastik M, Pastorino L, Wulf G, Zhou XZ, Lu KP (2009b) Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance. Nat Cell Biol 11:97–105
Lee TH, Chen CH, Suizu F, Huang P, Schiene-Fischer C, Daum S, Zhang YJ, Goate A, Chen RH, Zhou XZ, Lu KP (2011a) Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function. Mol Cell 42:147–159
Lee TH, Pastorino L, Lu KP (2011b) Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease. Expert Rev Mol Med 13:e21
Li X, Jiang Y, Meisenhelder J, Yang W, Hawke DH, Zheng Y, Xia Y, Aldape K, He J, Hunter T, Wang L, Lu Z (2016) Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis. Mol Cell 61:705–719
Liao Y, Wei Y, Zhou X, Yang JY, Dai C, Chen YJ, Agarwal NK, Sarbassov D, Shi D, Yu D, Hung MC (2009) Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation. Oncogene 28:2436–2445. doi:10.1038/onc.2009.98
Liu T, Schneider RA, Shah V, Huang Y, Likhotvorik RI, Keshvara L, Hoyt DG (2009) Protein Never in Mitosis Gene A Interacting-1 regulates calpain activity and the degradation of cyclooxygenase-2 in endothelial cells. J Inflamm (Lond) 6:20
Liu T, Liu Y, Kao HY, Pei D (2010) Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1. J Med Chem 53:2494–2501
Lonati E, Brambilla A, Milani C, Masserini M, Palestini P, Bulbarelli A (2014) Pin1, a new player in the fate of HIF-1alpha degradation: an hypothetical mechanism inside vascular damage as Alzheimer’s disease risk factor. Front Cell Neurosci 8:1. doi:10.3389/fncel.2014.00001
Lu KP (2003) Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell 4:175–180
Lu Z, Hunter T (2014) Prolyl isomerase Pin1 in cancer. Cell Res 24:1033–1049
Lu KP, Zhou XZ (2007) The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol 8:904–916
Lu KP, Hanes SD, Hunter T (1996) A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380:544–547
Lu PJ, Wulf G, Zhou XZ, Davies P, Lu KP (1999a) The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399:784–788
Lu PJ, Zhou XZ, Shen M, Lu KP (1999b) A function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science (N Y) 283:1325–1328
Lu KP, Liou YC, Zhou XZ (2002a) Pinning down the proline-directed phosphorylation signaling. Trends Cell Biol 12:164–172
Lu PJ, Zhou XZ, Liou YC, Noel JP, Lu KP (2002b) Critical role of WW domain phosphorylation in regulating its phosphoserine-binding activity and the Pin1 function. J Biol Chem 277:2381–2384
Lufei C, Koh TH, Uchida T, Cao X (2007) Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity. Oncogene 26:7656–7664. doi:10.1038/sj.onc.1210567
Luo Z, Wijeweera A, Oh Y, Liou YC, Melamed P (2010) Pin1 facilitates the phosphorylation-dependent ubiquitination of SF-1 to regulate gonadotropin beta-subunit gene transcription. Mol Cell Biol 30:745–763. doi:10.1128/MCB.00807-09
Luo ML, Gong C, Chen CH, Lee DY, Hu H, Huang P, Yao Y, Guo W, Reinhardt F, Wulf G, Lieberman J, Zhou XZ, Song E, Lu KP (2014) Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer. Cancer Res 74:3603–3616
Luo ML, Gong C, Chen CH, Hu H, Huang P, Zheng M, Yao Y, Wei S, Wulf G, Lieberman J, Zhou XZ, Song E, Lu KP (2015) The Rab2A GTPase promotes breast cancer stem cells and tumorigenesis via Erk signaling activation. Cell Rep 11:111–124
Lv L, Zhang J, Zhang L, Xue G, Wang P, Meng Q, Liang W (2013) Essential role of Pin1 via STAT3 signalling and mitochondria-dependent pathways in restenosis in type 2 diabetes. J Cell Mol Med 17:989–1005. doi:10.1111/jcmm.12082
Min SH, Lau AW, Lee TH, Inuzuka H, Wei S, Huang P, Shaik S, Lee DY, Finn G, Balastik M, Chen CH, Luo M, Tron AE, Decaprio JA, Zhou XZ, Wei W, Lu KP (2012) Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase. Mol Cell 46:771–783. doi:10.1016/j.molcel.2012.04.012
Mitchell MJ, Smith SL (1988) Effects of the chitin synthetase inhibitor plumbagin and its 2-demethyl derivative juglone on insect ecdysone 20-monooxygenase activity. Experientia 44:990–991
Monje P, Hernandez-Losa J, Lyons RJ, Castellone MD, Gutkind JS (2005) Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J Biol Chem 280:35081–35084. doi:10.1074/jbc.C500353200
Moore JD, Potter A (2013) Pin1 inhibitors: pitfalls, progress and cellular pharmacology. Bioorg Med Chem Lett 23:4283–4291
Moretto-Zita M, Jin H, Shen Z, Zhao T, Briggs SP, Xu Y (2010) Phosphorylation stabilizes Nanog by promoting its interaction with Pin1. Proc Natl Acad Sci USA 107:13312–13317. doi:10.1073/pnas.1005847107
Nakatsu Y, Iwashita M, Sakoda H, Ono H, Nagata K, Matsunaga Y, Fukushima T, Fujishiro M, Kushiyama A, Kamata H, Takahashi S, Katagiri H, Honda H, Kiyonari H, Uchida T, Asano T (2015) Prolyl isomerase Pin1 negatively regulates AMP-activated protein kinase (AMPK) by associating with the CBS domain in the gamma subunit. J Biol Chem 290:24255–24266. doi:10.1074/jbc.M115.658559
Nakayama K, Hatakeyama S, Maruyama S, Kikuchi A, Onoe K, Good RA, Nakayama KI (2003) Impaired degradation of inhibitory subunit of NF-kappa B (I kappa B) and beta-catenin as a result of targeted disruption of the beta-TrCP1 gene. Proc Natl Acad Sci USA 100:8752–8757
Nicole Tsang YH, Wu XW, Lim JS, Wee Ong C, Salto-Tellez M, Ito K, Ito Y, Chen LF (2013) Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer. Oncogene 32:1488–1496. doi:10.1038/onc.2012.178
Nishi M, Akutsu H, Masui S, Kondo A, Nagashima Y, Kimura H, Perrem K, Shigeri Y, Toyoda M, Okayama A, Hirano H, Umezawa A, Yamamoto N, Lee SW, Ryo A (2011) A distinct role for Pin1 in the induction and maintenance of pluripotency. J Biol Chem 286:11593–11603. doi:10.1074/jbc.M110.187989
Nishi M, Sakai Y, Akutsu H, Nagashima Y, Quinn G, Masui S, Kimura H, Perrem K, Umezawa A, Yamamoto N, Lee SW, Ryo A (2014) Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors. Oncogene 33:643–652. doi:10.1038/onc.2012.614
Pang R, Lee TK, Poon RT, Fan ST, Wong KB, Kwong YL, Tse E (2007) Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology 132:1088–1103. doi:10.1053/j.gastro.2006.12.030
Pani E, Menigatti M, Schubert S, Hess D, Gerrits B, Klempnauer KH, Ferrari S (2008) Pin1 interacts with c-Myb in a phosphorylation-dependent manner and regulates its transactivation activity. Biochim Biophys Acta 1783:1121–1128. doi:10.1016/j.bbamcr.2008.02.020
Pastorino L, Sun A, Lu PJ, Zhou XZ, Balastik M, Finn G, Wulf G, Lim J, Li SH, Li X, Xia W, Nicholson L, Lu KP (2006) The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 440:528–534
Peloponese JM Jr, Yasunaga J, Kinjo T, Watashi K, Jeang KT (2009) Peptidylproline cis-trans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 tax and modulates its activation of NF-kappaB. J Virol 83:3238–3248. doi:10.1128/JVI.01824-08
Penela P, Rivas V, Salcedo A, Mayor F Jr (2010) G protein-coupled receptor kinase 2 (GRK2) modulation and cell cycle progression. Proc Natl Acad Sci USA 107:1118–1123. doi:10.1073/pnas.0905778107
Ranganathan R, Lu KP, Hunter T, Noel JP (1997) Structural and functional analysis of the mitotic peptidyl-prolyl isomerase Pin1 suggests that substrate recognition is phosphorylation dependent. Cell 89:875–886
Rangasamy V, Mishra R, Sondarva G, Das S, Lee TH, Bakowska JC, Tzivion G, Malter JS, Rana B, Lu KP, Kanthasamy A, Rana A (2012) Mixed-lineage kinase 3 phosphorylates prolyl-isomerase Pin1 to regulate its nuclear translocation and cellular function. Proc Natl Acad Sci USA 109:8149–8154. doi:10.1073/pnas.1200804109
Reineke EL, Lam M, Liu Q, Liu Y, Stanya KJ, Chang KS, Means AR, Kao HY (2008) Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells. Mol Cell Biol 28:997–1006. doi:10.1128/MCB.01848-07
Rustighi A, Zannini A, Tiberi L, Sommaggio R, Piazza S, Sorrentino G, Nuzzo S, Tuscano A, Eterno V, Benvenuti F, Santarpia L, Aifantis I, Rosato A, Bicciato S, Zambelli A, Del Sal G (2014) Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast. EMBO Mol Med 6:99–119. doi:10.1002/emmm.201302909
Ryo A, Nakamura N, Wulf G, Liou YC, Lu KP (2001) Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol 3:793–801
Ryo A, Liou YC, Wulf G, Nakamura N, Lee SW, Lu KP (2002) Pin1 is an E2F target gene essential for the Neu/Ras-induced transformation of mammary epithelial cells. Mol Cell Biol 22:5281–5295
Ryo A, Hirai A, Nishi M, Liou YC, Perrem K, Lin SC, Hirano H, Lee SW, Aoki I (2007) A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx. J Biol Chem 282:36671–36681. doi:10.1074/jbc.M704145200
Ryo A, Wulf G, Lee TH, Lu KP (2009) Pinning down HER2-ER crosstalk in SMRT regulation. Trends Biochem Sci 34:162–165
Shen ZJ, Esnault S, Schinzel A, Borner C, Malter JS (2009) The peptidyl-prolyl isomerase Pin1 facilitates cytokine-induced survival of eosinophils by suppressing Bax activation. Nat Immunol 10:257–265. doi:10.1038/ni.1697
Shi M, Chen L, Ji J, Cai Q, Yu Y, Liu B, Zhu Z, Zhang J (2014) Pin1 is overexpressed and correlates with poor prognosis in gastric cancer. Cell Biochem Biophys 71:857–864
Steger M, Murina O, Huhn D, Ferretti LP, Walser R, Hanggi K, Lafranchi L, Neugebauer C, Paliwal S, Janscak P, Gerrits B, Del Sal G, Zerbe O, Sartori AA (2013) Prolyl isomerase PIN1 regulates DNA double-strand break repair by counteracting DNA end resection. Mol Cell 50:333–343. doi:10.1016/j.molcel.2013.03.023
Suizu F, Ryo A, Wulf G, Lim J, Lu KP (2006) Pin1 regulates centrosome duplication and its overexpression induces centrosome amplification, chromosome instability and oncogenesis. Mol Cell Biol 26:1463–1479
Takahashi K, Akiyama H, Shimazaki K, Uchida C, Akiyama-Okunuki H, Tomita M, Fukumoto M, Uchida T (2007) Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1. Oncogene 26:3835–3845
Takahashi K, Uchida C, Shin RW, Shimazaki K, Uchida T (2008) Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer’s disease. Cell Mol Life Sci CMLS 65:359–375. doi:10.1007/s00018-007-7270-0
Tatara Y, Lin YC, Bamba Y, Mori T, Uchida T (2009) Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1. Biochem Biophys Res Commun 384:394–398
Tong Y, Ying H, Liu R, Li L, Bergholz J, Xiao ZX (2015) Pin1 inhibits PP2A-mediated Rb dephosphorylation in regulation of cell cycle and S-phase DNA damage. Cell Death Dis 6:e1640. doi:10.1038/cddis.2015.3
Tun-Kyi A, Finn G, Greenwood A, Nowak M, Lee TH, Asara JM, Tsokos GC, Fitzgerald K, Israel E, Li X, Exley M, Nicholson LK, Lu KP (2011) Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity. Nat Immunol 12:733–741
Uchida T, Takamiya M, Takahashi M, Miyashita H, Ikeda H, Terada T, Matsuo Y, Shirouzu M, Yokoyama S, Fujimori F, Hunter T (2003) Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem Biol 10:15–24
Ueberham U, Rohn S, Ueberham E, Wodischeck S, Hilbrich I, Holzer M, Bruckner MK, Gruschka H, Arendt T (2014) Pin1 promotes degradation of Smad proteins and their interaction with phosphorylated tau in Alzheimer’s disease. Neuropathol Appl Neurobiol 40:815–832. doi:10.1111/nan.12163
Urusova DV, Shim JH, Kim DJ, Jung SK, Zykova TA, Carper A, Bode AM, Dong Z (2011) Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1. Cancer Prev Res 4:1366–1377
van Tiel CM, Kurakula K, Koenis DS, van der Wal E, de Vries CJ (2012) Dual function of Pin1 in NR4A nuclear receptor activation: enhanced activity of NR4As and increased Nur77 protein stability. Biochim Biophys Acta 1823:1894–1904
Wang HY, Fu JC, Lee YC, Lu PJ (2013) Hyperthermia stress activates heat shock protein expression via propyl isomerase 1 regulation with heat shock factor 1. Mol Cell Biol 33:4889–4899
Wang T, Liu Z, Shi F, Wang J (2016) Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/beta-catenin signaling pathway in cervical cancer. Mol Cell Biochem 413:179–187
Wei S, Kozono S, Kats L, Nechama M, Li W, Guarnerio J, Luo M, You MH, Yao Y, Kondo A, Hu H, Bozkurt G, Moerke NJ, Cao S, Reschke M, Chen CH, Rego EM, Lo-Coco F, Cantley LC, Lee TH, Wu H, Zhang Y, Pandolfi PP, Zhou XZ, Lu KP (2015) Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer. Nat Med 21:457–466
Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN, Clurman BE (2004) The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci USA 101:9085–9090
Wildemann D, Erdmann F, Alvarez BH, Stoller G, Zhou XZ, Fanghanel J, Schutkowski M, Lu KP, Fischer G (2006) Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries. J Med Chem 49:2147–2150
Wildemann D, Hernandez Alvarez B, Stoller G, Zhou XZ, Lu KP, Erdmann F, Ferrari D, Fischer G (2007) An essential role for Pin1 in Xenopus laevis embryonic development revealed by specific inhibitors. Biol Chem 388:1103–1111
Wulf GM, Ryo A, Wulf GG, Lee SW, Niu T, Lu KP (2001) Pin1 is overexpressed in breast cancer and potentiates the transcriptional activity of phosphorylated c-Jun towards the cyclin D1 gene. EMBO J 20:3459–3472
Wulf G, Garg P, Liou YC, Iglehart D, Lu KP (2004) Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J 23:3397–3407
Wulf G, Finn G, Suizu F, Lu KP (2005) Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat Cell Biol 7:435–441
Xu GG, Etzkorn FA (2009) Pin1 as an anticancer drug target. Drug News Perspect 22:399–407
Xu YX, Manley JL (2007) The prolyl isomerase pin1 functions in mitotic chromosome condensation. Mol Cell 26:287–300
Xu C, Kim NG, Gumbiner BM (2009) Regulation of protein stability by GSK3 mediated phosphorylation. Cell Cycle (Georget Tex) 8:4032–4039
Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, Ishida N, Okumura F, Nakayama K, Nakayama KI (2004) Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 23:2116–2125
Yaffe MB, Schutkowski M, Shen M, Zhou XZ, Stukenberg PT, Rahfeld J, Xu J, Kuang J, Kirschner MW, Fischer G, Cantley LC, Lu KP (1997) Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science (N Y) 278:1957–1960
Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo F, Lyssiotis CA, Aldape K, Cantley LC, Lu Z (2012) ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol 14:1295–1304. doi:10.1038/ncb2629
Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenolikar S, Uchida T, Counter CM, Nevins JR, Means AR, Sears R (2004) A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 6:308–318. doi:10.1038/ncb1110
Yi P, Wu RC, Sandquist J, Wong J, Tsai SY, Tsai MJ, Means AR, O’Malley BW (2005) Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1). Mol Cell Biol 25:9687–9699. doi:10.1128/MCB.25.21.9687-9699.2005
Yu L, Mohamed AJ, Vargas L, Berglof A, Finn G, Lu KP, Smith CI (2006) Regulation of Bruton tyrosine kinase by the peptidylprolyl isomerase Pin1. J Biol Chem 281:18201–18207. doi:10.1074/jbc.M603090200
Zhang Y, Daum S, Wildemann D, Zhou XZ, Verdecia MA, Bowman ME, Lucke C, Hunter T, Lu KP, Fischer G, Noel JP (2007) Structural basis for high-affinity peptide inhibition of human Pin1. ACS Chem Biol 2:320–328
Zheng Y, Xia Y, Hawke D, Halle M, Tremblay ML, Gao X, Zhou XZ, Aldape K, Cobb MH, Xie K, He J, Lu Z (2009) FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST. Mol Cell 35:11–25. doi:10.1016/j.molcel.2009.06.013
Zheng Y, Yang W, Xia Y, Hawke D, Liu DX, Lu Z (2011) Ras-induced and extracellular signal-regulated kinase 1 and 2 phosphorylation-dependent isomerization of protein tyrosine phosphatase (PTP)-PEST by PIN1 promotes FAK dephosphorylation by PTP-PEST. Mol Cell Biol 31:4258–4269. doi:10.1128/MCB.05547-11
Zhou XZ, Lu KP (2016) The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target. Nat Rev Cancer 16(7):463–478. doi:10.1038/nrc.2016.49
Acknowledgments
Drs. Lu and Dr. Zhou are inventors of Pin1 technology, which was licensed by BIDMC to Pinteon Therapeutics. Both Dr. Lu and Dr. Zhou own equity in, and consult for, Pinteon and their interests were reviewed and are managed by BIDMC in accordance with its conflict of interest policy. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (2013-R1A1A1007596 and 2015M3A9C7030181). Work conducted in the authors’ laboratories is supported by National Institutes of Health (NIH) grants R01CA167677, R03DA031663, R01HL111430, R01AG029385 and R01AG046319, by the Alzheimer’s Association grant DVT-14-322623, and the National Natural Science Foundation of China (NSFC) grant U1205024 to K.P.L. Work is also supported by a Beth Israel Deaconess Medical Center pilot grant and generous gift donations from the Owens Family Foundation to X.Z.Z. and K.P.L.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest with the contents of this article.
Additional information
Sang-Hyun Min, Xiao Zhen Zhou, and Kun Ping Lu contributed equally to this work.
Rights and permissions
About this article
Cite this article
Min, SH., Zhou, X.Z. & Lu, K.P. The role of Pin1 in the development and treatment of cancer. Arch. Pharm. Res. 39, 1609–1620 (2016). https://doi.org/10.1007/s12272-016-0821-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-016-0821-x